CAMPSQ11362
Title : T-20
Source : Synthetic construct
PubMed : 30716118
Activity : Antiviral
Target :
NL4-3 ( IC50= 47386.67 +/- 4815.83 pM), LAI ( IC50= 1163.33 +/- 102.94 pM), SG3 ( IC50= 2851.32 +/- 226.64 pM), JR-CSF ( IC50= 2968.33 +/- 788.34 pM), WITO.c/2474 ( IC50= 7810.56 +/- 1624.26 pM), RHPA.c/2635 ( IC50= 6517.44 +/- 1329.99 pM), THRO.c/2626 ( IC50= 31310 +/- 2387.75 pM), CH040.c/2625 ( IC50= 30883.33 +/- 3805.27 pM), 89.6 ( IC50= 15431.01 +/- 5882.09 pM), R3A ( IC50= 6731.67 +/- 1082.18 pM)
Validated : Experimentally validated
Length : 36
Sequence:
YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF

| © 2022, Biomedical Informatics Centre, ICMR-NIRRCH |
ICMR-National Institute for Research in Reproductive and Child Health, Jehangir Merwanji Street, Parel, Mumbai-400012
Maharashtra, India